For: | Li W, Li DD, Yin B, Lin DD, Sheng HS, Zhang N. Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant Acinetobacter baumannii with multi-route tigecycline: A case report. World J Clin Cases 2021; 9(3): 651-658 [PMID: 33553404 DOI: 10.12998/wjcc.v9.i3.651] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i3/651.htm |
Number | Citing Articles |
1 |
Ziyu Li, Yuling An, Lijuan Li, Huimin Yi. Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the Literature. Infection and Drug Resistance 2022; : 1411 doi: 10.2147/IDR.S354460
|
2 |
Qi Huang, Xingwen Zhang, Aijun Jia, Qi Huang, Yu Jiang, Liangyi Xie. The Pharmacokinetics/Pharmacodynamics and Neurotoxicity of Tigecycline Intraventricular Injection for the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Intracranial Infection. Infection and Drug Resistance 2022; : 4809 doi: 10.2147/IDR.S377772
|
3 |
Antonio Mastroianni, Valeria Vangeli, Maria Vittoria Mauro, Filippo Urso, Roberto Manfredi, Sonia Greco. Intrathecal tigecycline is a safe and effective treatment for central nervous system infections. encephalitis 2023; 3(3): 87 doi: 10.47936/encephalitis.2023.00010
|
4 |
Ning Du, En-Qiang Mao, Zhi-Tao Yang, Hong-Ping Qu, Xian Qian, Ying Shi, Xiao-Lan Bian, Juan He, Er-Zhen Chen. Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae. Infection and Drug Resistance 2022; : 7219 doi: 10.2147/IDR.S387346
|